pharma · Glaucoma · Macular Edema
Allergan Pharmaceuticals International
Allergan Pharmaceuticals International Limited
Allergan Pharmaceuticals International is a pharma organization headquartered in Dublin, IE. Primary therapeutic focus areas include Glaucoma, Macular Edema, Macular Degeneration, Dry Eye Syndromes, Choroid Neovasculariz
Dublin, IE HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dublin, IE
- Programs
- 13
- Drugs
- 15
- Patents
- 25
AGN 211745
Phase 2 · small molecule · Choroid Neovascularization
AGN 211745 for Choroid Neovascularization is a Phase 2 program (small_molecule) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Internal code 211745-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Allergan Pharmaceuticals International Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Choroid Neovascularization
- Status
- terminated
- Trials
- 1